Apellis Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	133.27	22.39	-197.88	-528.63	-652.17	-746.35
Depreciation & Amortization	1.4	1.56	1.8	1.78	1.55	1.49
Other Amortization	2.57	2.5	1.56	0.3	0.46	0.96
Loss (Gain) From Sale of Assets	-	-	-	0.12	-	-
Stock-Based Compensation	101.8	104	114.13	105.95	91.09	70.67
Other Operating Activities	-	-	10.89	26	61.09	203.63
Change in Accounts Receivable	-205.03	-101.28	-58.48	-198.72	2.38	-10.1
Change in Inventory	-10.46	-15.27	-10.76	-60.65	-69.4	-16.32
Change in Accounts Payable	-6.23	18.22	1.09	0.17	18.69	10.49
Change in Other Net Operating Assets	20.45	13.21	49.79	58.94	32.57	-77.59
Operating Cash Flow	37.77	45.33	-87.87	-594.74	-513.75	-563.13
Operating Cash Flow Growth	-	-	-	-	-	-
Capital Expenditures	-0.31	-0.31	-0.4	-0.77	-1.52	-1.1
Sale of Property, Plant & Equipment	-	-	-	0.1	-	-
Investment in Securities	-	-	-	-	61.42	248.72
Investing Cash Flow	-0.31	-0.31	-0.4	-0.67	59.89	247.62
Long-Term Debt Issued	-	-	365.45	-	-	-
Net Debt Issued (Repaid)	-	-	365.45	-	-	-
Issuance of Common Stock	8.7	8.9	18.83	461.04	405.84	398.02
Repurchase of Common Stock	-0.03	-0.01	-0.06	-11.04	-5.68	-1.79
Other Financing Activities	-	-	-234.98	-55.5	-34.5	-4
Financing Cash Flow	8.67	8.88	149.24	394.5	365.66	392.24
Foreign Exchange Rate Adjustments	0.76	1.25	-0.66	0.14	-0.49	-2.02
Net Cash Flow	46.9	55.15	60.31	-200.78	-88.68	74.71
Free Cash Flow	37.47	45.01	-88.27	-595.51	-515.27	-564.23
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	3.39%	4.48%	-11.30%	-150.16%	-683.18%	-847.66%
Free Cash Flow Per Share	0.28	0.35	-0.71	-5.02	-4.86	-6.68
Levered Free Cash Flow	-63.65	-15.46	-35.7	-404.84	-304.6	-351.61
Unlevered Free Cash Flow	-38.97	9.74	-12.01	-386.65	-284.66	-344.3
Cash Interest Paid	40.62	41.23	29.37	3.29	5	10.27
Cash Income Tax Paid	1.56	1.63	1.65	-1.76	4.92	0.05
Change in Working Capital	-201.27	-85.12	-18.36	-200.25	-15.76	-93.52

SEC Filings: 10-K · 10-Q